World News: 12:50 GMT Friday 15th March 2019. [EQS Group via SPi World News]
DGAP-News: AlzChem Group AG / Key word(s): Product Launch
Trostberg, March 15, 2019 - With its creatine product LIVADUR(R), AlzChem Group AG will be addressing end consumers directly for the first time as of March 2019. The target audience consists of active people aged 55 and over who want to prevent the age-related decline in muscle strength and thus maintain their high quality of life and fitness. The dietary supplement is based on the already very successful product Creapure(R), the only creatine product manufactured in Germany that is supplied to the dietary supplement industry specifically for sports nutrition.
Ulli Seibel, CEO of AlzChem Group AG: 'With LIVADUR(R), we are opening up another important stage in the value chain by going as far as the end customer for the first time. We see excellent market opportunities as well as attractive margin potential here and are therefore striving to achieve nationwide availability in pharmacies before the end of this year. In the future, we also want to internationalize the product, with which we specifically serve the megatrend of healthy aging, particularly in the US and Chinese markets. There are a variety of approaches here for additional growth opportunities. In the medium term, LIVADUR(R) has the potential to become an important pillar in the product mix.'
|Company:||AlzChem Group AG|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart|
|End of News||DGAP News Service|
Read More: http://www.dgap.de/dgap/News/?eqsNewsID=1760643
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.